Evidence map›Paper›PMID 40337377›Full record

ArticleAnnals of medicine and surgery (2012)2025

Xeroderma pigmentosa associated with spindle cell carcinoma of lung: a case report.

Bibek Shrestha, Grishma Kandel, Dhiraj Adhikari, Sudip Bastakoti, Abhinash Mishra

Abstract readCase Reports
In one paragraph

Article in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bibek ShresthaMaharajgunj Medical Campus, Tribhuvan University, Institute of Medicine, Kathmandu Nepal.
Grishma KandelMaharajgunj Medical Campus, Tribhuvan University, Institute of Medicine, Kathmandu Nepal.
Dhiraj AdhikariMaharajgunj Medical Campus, Tribhuvan University, Institute of Medicine, Kathmandu Nepal.
Sudip BastakotiDepartment of Internal Medicine, Tribhuvan University Teaching Hospital, Kathmandu Nepal.
Abhinash MishraMaharajgunj Medical Campus, Tribhuvan University, Institute of Medicine, Kathmandu Nepal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction and importance: Xeroderma pigmentosum is a rare autosomal recessive genetic disorder characterized by defective nucleotide excision repair, leading to extreme sensitivity to ultraviolet radiation, skin pigmentation changes, and a heightened risk of malignancies. Neurological symptoms, such as seizures and cognitive decline, are observed in 20% of cases. While xeroderma pigmentosa is commonly associated with skin cancers, systemic malignancies like lung carcinoma are exceedingly rare. Case presentation: A 22-year-old male with a history of xeroderma pigmentosa presented with a six-month history of non-productive cough, hemoptysis, intermittent fever, and episodic jerky movements in his upper limb. Examination revealed hypo- and hyperpigmented macules, cachexia, cervical lymphadenopathy, and diminished air entry in the left lung. Blood tests indicated leukocytosis, elevated ESR, and abnormal electrolyte levels. Imaging confirmed a left lower lobe lung mass, and biopsy revealed spindle cell carcinoma with p53 positivity on immunohistochemistry. Clinical discussion: Spindle cell carcinoma is a rare and aggressive subtype of non-small-cell lung cancer, comprising 0.2-0.3% of pulmonary malignancies. Its association with XP is notable, as defective DNA repair mechanisms in xeroderma pigmentosa predispose patients to malignancies driven by p53 mutations. This case emphasizes the need for vigilance for systemic malignancies in XP patients. Conclusion: This is the first reported case of xeroderma pigmentosa associated with spindle cell carcinoma of the lung and focal seizures. It underscores the importance of early recognition and comprehensive surveillance for rare malignancies in XP patients, given their elevated cancer risk. The patient opted for palliative care and was symptomatically managed.

Indexed as

DNA damagespindle cell carcinomaultraviolet raysxeroderma pigmentosum

Identifiers

PMID40337377
PMCPMC12055150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.